Oculus Nova addresses the challenges in treating amblyopia, especially in children, where traditional methods like eyepatching and atropine drops often lead to low compliance due to discomfort, lack of engagement, and social stigma. This gamified vision therapy application aims to make treatment more interactive, enjoyable, and effective. Oculus Nova incorporates two distinct therapeutic approaches. The first encourages the use of an eye patch through a reward-based game system that detects whether the patch is worn—only granting access or in-game boosts if therapy compliance is met. The second approach utilizes red-blue 3D glasses to deliver layered visual stimuli: the amblyopic eye (red lens) perceives clearer game visuals while the stronger eye (blue lens) sees blurred content. This approach mimics occlusion therapy in a less intrusive, more engaging way. To further improve therapy outcomes, Oculus Nova includes a progress tracker that logs user performance and logMAR readings, providing valuable insights for therapists and guardians to make data-driven decisions. The application also incorporates screen time monitoring based on the 20/20/20 rule—20-minute sessions, up to three times daily—to promote healthy visual habits and reduce digital eye strain. Using eye-tracking technology and gamified elements, Oculus Nova redefines vision therapy by enhancing motivation, engagement, and consistency. Ultimately, the project aims to improve vision outcomes while offering a more positive therapeutic journey for young users.